Figure 1.
Pleiotropic effects of sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors. BP, blood pressure; NHE1, sodium‐hydrogen exchanger 1; NHE3, sodium‐hydrogen exchanger 3; RAAS, renin‐angiotensin aldosterone system
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.